GSE145340 19p loss is significantly enriched in older age neuroblastoma patients and correlates with poor prognosis (Agilent-022060)

Contributor : Annalisa PezzoloSeries Type : Genome variation profiling by arrayOrganism : Homo sapiensGenomic aberrations of neuroblastoma occurring in late childhood and adolescence are uncommon and still underestimated.Public DNA copy number profiles of 556 tumors (discovery set) and of 208 tumors obtained by array-CGH assay (validation set) were used to verify if 19p loss is significantly over-represented in children and adolescents. The 19p loss occurrence was separately tested within different age groups in the discovery and validation set and the resulting P values were combined and corrected by Bonferroni ’s method.In both sets, the lowest age group significantly associated with 19p loss (discovery set: 20%; validation set: 35%) was 6 years. The 19p loss was considered to be a significant marker for overall survival in patients over 6 years of age. Relevant tumor suppressor genes (KEAP1, DNM2, SMARCA4, SLC44A2 and CDKN2D) and microRNAs (miR-181c, miR-27a, and mirR-199a-1) were in 19p loss. Down-regulation of DNM2, SLC44A2 and CDKN2D associated with poor patient outcome and older age. Among the recurrent NB chromosomal aberrations, only 1q gain was enriched in patients older than 6 years and was mutually exclusive respect to 19p loss.Our data demonstrate that 19p loss is a genomic biomarker of NBs diagnosed in older children that can predict clinical outcome.
Source: GEO: Gene Expression Omnibus - Category: Genetics & Stem Cells Tags: Genome variation profiling by array Homo sapiens Source Type: research

Related Links:

Source: Cancer Management and Research - Category: Cancer & Oncology Tags: Cancer Management and Research Source Type: research
This video covers key aspects of neuroblastoma, including the causes, symptoms, diagnosis, and treatment.Osmosis
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Med Students Commentary Source Type: news
We identified 20 survival ‐related long noncoding RNAs (lncRNAs) that might be associated with the spontaneous regression of neuroblastoma (NB) and developed a four‐lncRNA signature risk score. The four‐lncRNA signature is an independent prognostic factor of survival in NB. AbstractBackgroundThe association between long noncoding RNAs (lncRNAs) and spontaneous regression of neuroblastoma (NB) has rarely been investigated and remains unknown.ObjectiveTo identify prognostic lncRNAs involved in the spontaneous regression of NB.MethodsDifferential expression analyses were performed between those samples with an outcome o...
Source: Cancer Medicine - Category: Cancer & Oncology Authors: Tags: ORIGINAL RESEARCH Source Type: research
Chemical Research in ToxicologyDOI: 10.1021/acs.chemrestox.9b00437
Source: Chemical Research in Toxicology - Category: Toxicology Authors: Source Type: research
In this study, 4‐F4t‐NeuroP was introduced into neuroblastoma cells (SH‐SY5Y) and, byin vivo infusion, into rodents. Targeted lipidomic analysis of liver and brain tissues show significant elevation of anti ‐inflammatory hydroxylated‐DHA metabolites and an isomer of neuroprotectin D1, suggesting potential beneficial bioactivities of 4‐F4t‐NeuroP. Additionally, 4‐F4t‐NeuroP treatment in SH‐SY5Y cells and primary neuronal culture consistently upregulates the transcriptional level of the antioxidant enzyme hemeoxygenase‐1, but the effect is reduced when 4‐F4t‐NeuroP is further oxidized. Our data sugg...
Source: FEBS Letters - Category: Biochemistry Authors: Tags: COMMUNICATION Source Type: research
Aerobic glycolysis is a hallmark of metabolic reprogramming that contributes to tumor progression. However, the mechanisms regulating expression of glycolytic genes in neuroblastoma (NB), the most common extra...
Source: Journal of Hematology and Oncology - Category: Hematology Authors: Tags: Research Source Type: research
AbstractObjectiveThe aim of the study was to investigate the outcomes and prognostic factors of high-dose131I-metaiodobenzylguanidine (131I-MIBG) therapy in patients with refractory or relapsed neuroblastoma (NBL) in Japan.MethodsWe retrospectively analyzed 20 patients with refractory or relapsed high-risk NBL who underwent131I-MIBG therapy with an administration dose ranging from 444 to 666  MBq/kg at Kanazawa University Hospital, Japan, between September 2008 and September 2013. We focused on measurements regarding their initial responses, prognostic factors, survivals, and toxicities following131I-MIBG therapy usin...
Source: Annals of Nuclear Medicine - Category: Nuclear Medicine Source Type: research
Conditions:   Hematopoietic and Lymphoid Cell Neoplasm;   Recurrent Ependymoma;   Recurrent Ewing Sarcoma;   Recurrent Hepatoblastoma;   Recurrent Histiocytic and Dendritic Cell Neoplasm;   Recurrent Langerhans Cell Histiocytosis;   Recurrent Lymphoma;   Recurrent Malignant Germ Cel l Tumor;   Recurrent Malignant Glioma;   Recurrent Malignant Solid Neoplasm;   Recurrent Medulloblastoma;   Recurrent Neuroblastoma;   Recurr...
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
In this study, 4‐F4t‐NeuroP was introduced into neuroblastoma cells (SH‐SY5Y) and, byin vivo infusion, into rodents. Targeted lipidomic analysis of liver and brain tissues show significant elevation of anti ‐inflammatory hydroxylated‐DHA metabolites and an isomer of neuroprotectin D1, suggesting potential beneficial bioactivities of 4‐F4t‐NeuroP. Additionally, 4‐F4t‐NeuroP treatment in SH‐SY5Y cells and primary neuronal culture consistently upregulates the transcriptional level of the antioxidant enzyme hemeoxygenase‐1, but the effect is reduced when 4‐F4t‐NeuroP is further oxidized. Our data sugg...
Source: FEBS Letters - Category: Biochemistry Authors: Tags: COMMUNICATION Source Type: research
Abstract Enterovirus A71 (EV71) remains the most common causative agent of hand, foot, and mouth disease (HFMD), and the neurological complications induced by EV71 are usually the leading cause of death in children with HFMD. However, the mechanism of nervous system changes caused by EV71 infection is still unclear. Therefore, in the current study, EV71 was inoculated into the human neuroblastoma cell line SH-SY5Y and subsequent transcriptome sequencing was used to examine the alterations of the transcriptome in infected SH-SY5Y cells. It is expected to determine the underlying mechanism of neurological diseases i...
Source: Virus Research - Category: Virology Authors: Tags: Virus Res Source Type: research
More News: Brain | Children | Genetics | Neuroblastoma | Neurology